We drive innovative research, develop potential therapies, organize scientific conferences and sponsor a multidisciplinary clinical center for ataxia-telangiectasia (A-T), a fatal genetic disease that attacks children, causing progressive loss of muscle control, cancer, and immune system problems.
Antisense Oligonucleotide Therapy
Producing the functional ATM protein that is missing within the cells of children with A-T